Free Trial

Aridis Pharmaceuticals (ARDS) SEC Filings & 10K Form

Aridis Pharmaceuticals logo
$0.0001 +0.00 (+∞)
(As of 12/20/2024 02:47 PM ET)

Recent Aridis Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/28/2024
7:36 PM
Aridis Pharmaceuticals (Issuer)
HAMILTON JOHN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
7:36 PM
Aridis Pharmaceuticals (Issuer)
Windham-Bannister Susan Richards (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:46 PM
Aridis Pharmaceuticals (Issuer)
Jafri Hasan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:32 PM
Aridis Pharmaceuticals (Issuer)
Patzer Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:29 PM
Aridis Pharmaceuticals (Issuer)
Truong Vu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
Aridis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
1:21 PM
Aridis Pharmaceuticals (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G/A
02/13/2024
7:02 PM
Aridis Pharmaceuticals (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
01/16/2024
5:05 AM
Aridis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ARDS) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners